FDA Inspection
Tennessee Blood Services CorpTennessee Blood Services Corp – FDA Inspection, Apr 12, 2018
Record Details
This FDA Inspection record concerns Tennessee Blood Services Corp, with an inspection on April 12, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 600fa5d6-c659-4505-8ec8-564821c64790
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1047818
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 610.47(a)Lookback System [Collecting Establishment]
- 21 CFR 610.46(b)Lookback System [Consignee]
- 21 CFR 630.10(g)(1)Proof Of Identity
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Tennessee Blood Services Corp
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2025 | VAI | New Orleans District Office | Blood and Blood Products |
| January 12, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 9, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 12, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 30, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Tennessee Blood Services Corp
- FDA Inspection 1270402 - 2025-05-08
- FDA Inspection 1195155 - 2023-01-12
- FDA Inspection 977685 - 2016-06-09
- FDA Inspection 877404 - 2014-05-12
- FDA Inspection 750050 - 2011-09-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.